I’m Dr. Michael Richman, a double board certified cardiothoracic surgeon. I have been asked by many of you to talk about the peptide Cerebrolysin. Cerebrolysin is used in approximately 50 countries in Europe and Asia for treatment after a Stroke, for Dementia (Alzheimers and Vascular Dementia), and after a Traumatic Brian Injury. Does it improve cognition, does it prevent or treat Dementia? The questions go on and on. If if has shown efficacy, why isn’t it used in the United States and approved by the FDA? In today’s video, I provide the evidence-based literature and the facts!